| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial MD Tameris, M Hatherill, BS Landry, TJ Scriba, MA Snowden, S Lockhart, ... The Lancet 381 (9871), 1021-1028, 2013 | 1243 | 2013 |
| Identifying specificity groups in the T cell receptor repertoire J Glanville, H Huang, A Nau, O Hatton, LE Wagar, F Rubelt, X Ji, A Han, ... Nature 547 (7661), 94-98, 2017 | 981 | 2017 |
| A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 824 | 2016 |
| Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination E Nemes, H Geldenhuys, V Rozot, KT Rutkowski, F Ratangee, N Bilek, ... New England Journal of Medicine 379 (2), 138-149, 2018 | 689 | 2018 |
| Immunological biomarkers of tuberculosis G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla Nature Reviews Immunology 11 (5), 343-354, 2011 | 653 | 2011 |
| Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response TJ Scriba, B Kalsdorf, DA Abrahams, F Isaacs, J Hofmeister, G Black, ... The Journal of Immunology 180 (3), 1962-1970, 2008 | 553 | 2008 |
| Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ... New England Journal of Medicine 381 (25), 2429-2439, 2019 | 538 | 2019 |
| Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns BMN Kagina, B Abel, TJ Scriba, EJ Hughes, A Keyser, A Soares, ... American journal of respiratory and critical care medicine 182 (8), 1073-1079, 2010 | 514 | 2010 |
| T cells and adaptive immunity to Mycobacterium tuberculosis in humans LD Jasenosky, TJ Scriba, WA Hanekom, AE Goldfeld Immunological reviews 264 (1), 74-87, 2015 | 425 | 2015 |
| Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ... New England Journal of Medicine 379 (17), 1621-1634, 2018 | 416 | 2018 |
| Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening H Huang, C Wang, F Rubelt, TJ Scriba, MM Davis Nature biotechnology 38 (10), 1194-1202, 2020 | 370 | 2020 |
| T-cell activation is an immune correlate of risk in BCG vaccinated infants HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ... Nature communications 7 (1), 11290, 2016 | 319 | 2016 |
| Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells LJ Walker, YH Kang, MO Smith, H Tharmalingham, N Ramamurthy, ... Blood, The Journal of the American Society of Hematology 119 (2), 422-433, 2012 | 296 | 2012 |
| Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles AP Soares, TJ Scriba, S Joseph, R Harbacheuski, RA Murray, ... The Journal of Immunology 180 (5), 3569-3577, 2008 | 295 | 2008 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 284 | 2018 |
| COMPASS identifies T-cell subsets correlated with clinical outcomes L Lin, G Finak, K Ushey, C Seshadri, TR Hawn, N Frahm, TJ Scriba, ... Nature biotechnology 33 (6), 610-616, 2015 | 283 | 2015 |
| A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ... Nature 560 (7720), 644-648, 2018 | 266 | 2018 |
| Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells TJ Scriba, M Tameris, N Mansoor, E Smit, L van der Merwe, F Isaacs, ... European journal of immunology 40 (1), 279-290, 2010 | 265 | 2010 |
| Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease TJ Scriba, A Penn-Nicholson, S Shankar, T Hraha, EG Thompson, ... PLoS pathogens 13 (11), e1006687, 2017 | 235 | 2017 |
| Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis E Petruccioli, TJ Scriba, L Petrone, M Hatherill, DM Cirillo, SA Joosten, ... European Respiratory Journal 48 (6), 1751-1763, 2016 | 228 | 2016 |
Willem HanekomAfrica Health Research InstituteEmail verificata su ahri.org